《大行》招銀國際升特步(01368.HK)目標價至7.39元 中期業績勝預期
招銀國際發表研究報告指,特步(01368.HK)上半年業績勝於預期,踏入下半年,雖然宏觀環境仍然令人憂慮,但相信公司仍能達成其相當審慎的全年指引,即公司整體銷售額正增長,淨利潤增長10%以上,而索康尼(Saucony)的銷售則升30至40%。
該行表示,特步第三季的零售額增長趨勢較理想。報告引述管理層指,核心特步品牌與索康尼品牌於今年7月的零售額增速按年加快。
招銀國際上調特步2025財年的淨利潤預測3%,但下調2027財年預測3%,以反映其中期盈利勝於預期、毛利率遜於預期及索康尼經營溢利率優於預期。該行維持公司「買入」評級,目標價由7.2元上調至7.39元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.